Last 32.70 INR
Change Today -0.75 / -2.24%
Volume 1.5M
ARR On Other Exchanges
Symbol
Exchange
Natl India
As of 6:05 AM 11/21/14 All times are local (Market data is delayed by at least 15 minutes).

arvind remedies ltd (ARR) Snapshot

Open
33.85
Previous Close
33.45
Day High
34.00
Day Low
32.50
52 Week High
09/8/14 - 66.20
52 Week Low
07/24/14 - 30.00
Market Cap
2.2B
Average Volume 10 Days
3.8M
EPS TTM
9.95
Shares Outstanding
68.1M
EX-Date
09/24/14
P/E TM
3.3x
Dividend
0.80
Dividend Yield
2.45%
Current Stock Chart for ARVIND REMEDIES LTD (ARR)

Related News

No related news articles were found.

arvind remedies ltd (ARR) Related Businessweek News

No Related Businessweek News Found

arvind remedies ltd (ARR) Details

Arvind Remedies Limited manufactures and markets pharmaceutical products in India and internationally. The company provides allopathic products, including ethical products comprising analgesic/anti-inflammatory products, anti-infectives, antioxidants, anti rheumatic and anti spasmodic products, cough expectorants/nasal decongestants, haematinics, nutritional supplements, vitamins, hyperacidity and reflux ulcers, topical antipruritics, gonadal hormones, and anti asthmatics; branded generic products; and generic products. It also offers ayurvedic products, such as Artin oil for myalgias, arthralgias, frozen shoulders, stiff joints, arthritis, and musculoskeletal disorders of varied aetiology; Hygenex for leucorrhoea, non specific vaginitis, pruritis, dyspareunia, cervicitis, etc.; Pankare for diabetes mellitus; Solufat for hyperlipidaemias of varied aetiology; Sorexil for various skin ulcers bedsores, varicose ulcers, ulcers of insensitive foot, diabetic ulcers, and cuts and wounds; Stresof for conditions related to stress, aging and convalescence, and insomnia general debility and vitaliser; and Utritone for the treatment of leucorrhoea, non specific verginitis, pruritis, dysparunea, cervicitis, dysmenorrhoea, and oligomenorrhagea. In addition, the company provides contract manufacturing services. It serves defence establishments, ESI, CGHS, central and state government institutions, public sector companies, P&T, railways, and world bank projects. The company was incorporated in 1988 and is based in Chennai, India.

Founded in 1988

arvind remedies ltd (ARR) Top Compensated Officers

Chairman, Managing Director and Chief Executi...
Total Annual Compensation: 4.4M
Head of Marketing and Vice President
Total Annual Compensation: 1.9M
Whole-Time Director
Total Annual Compensation: 954.6K
Executive Director of Technical and Executive...
Total Annual Compensation: 2.0M
Compensation as of Fiscal Year 2014.

arvind remedies ltd (ARR) Key Developments

Arvind Remedies Ltd Reports Un-Audited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2014

Arvind Remedies Ltd. reported un-audited standalone earnings results for the second quarter and six months ended September 30, 2014. For the quarter, the company reported total income from operations (net) of INR 2,933.255 million compared to INR 2,196.515 million, profit from operations before other, finance cost & exceptional items of INR 355.614 million compared to INR 347.245 million, profit from ordinary activities before tax of INR 22.223 million compared to INR 178.617 million and net profit of INR 13.178 million or INR 0.19 per basic and diluted share compared to INR 131.271 million or INR 1.93 per basic and diluted share for the last year. EBITDA was INR 420 million against INR 381.1 million a year ago. For the six months, the company reported total income from operations (net) of INR 5,519.389 million compared to INR 4,034.914 million, profit from operations before other, finance cost & exceptional items of INR 924.848 million compared to INR 347.245 million, profit from ordinary activities before tax of INR 22.223 million compared to INR 715.372 million and net profit of INR 274.300 million or INR 4.03 per basic and diluted share compared to INR 296.572 million or INR 4.35 per basic and diluted share for the last year. EBITDA was INR 1,050 million against INR 773.4 million a year ago.

Arvind Remedies Ltd Announces Resignation of R. Rajamohan as Director

Arvind Remedies Ltd. announced that Mr. R. Rajamohan, Director has resigned from the company with effect from November 05, 2014. This was considered in the Board meeting of the Company held on November 13, 2014 and approved.

Arvind Remedies Ltd to Report Q2, 2015 Results on Nov 13, 2014

Arvind Remedies Ltd announced that they will report Q2, 2015 results on Nov 13, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARR:IN 32.70 INR -0.75

ARR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ARR.
View Industry Companies
 

Industry Analysis

ARR

Industry Average

Valuation ARR Industry Range
Price/Earnings 2.7x
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow 2.5x
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARVIND REMEDIES LTD, please visit www.arvindremedies.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.